An overview of the sickle cell and thalassaemia (SCT) screening end-to-end pathway. Category: UncategorisedBy 21 June 2021Leave a commentPost navigationPreviousPrevious post:Guidance: Abdominal aortic aneurysm screening pathway requirements specificationNextNext post:Guidance: Diabetic eye screening pathway requirements specification